GE HealthCare TechnologiesSTU:L0T -1.46%72 Piotroski F-Score is 6 as of Jun. 29, 2026, which is at its 10-year median of 6.00. GuruFocus rates STU:L0T with a GF Score™ of 72/100 and a GF Value™ of €74.58 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 806 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 81.02% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
GE HealthCare Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for GE HealthCare Technologies's Piotroski F-Score or its related term are showing as below:
STU:L0T'
s Piotroski F-Score Range Over the Past 10 Years
Min: 5 Med: 6 Max: 8
Current: 6
During the past 7 years, the highest Piotroski F-Score of GE HealthCare Technologies was 8. The lowest was 5. And the median was 6.
GE HealthCare Technologies (STU:L0T) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
GE HealthCare Technologies Piotroski F-Score Related Terms
GE HealthCare Technologies Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies Piotroski F-Score Chart
STU:L0T vs DXCM, STE, ZBH: Piotroski F-Score Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Mar26) TTM:
Last Year (Mar25) TTM:
Net Income was 421.362 + 379.992 + 503.006 + 336.485 = €1,641 Mil. Cash Flow from Operations was 81.498 + 505.236 + 896.7 + 250.85 = €1,734 Mil. Revenue was 4340.202 + 4382.688 + 4866.092 + 4438.315 = €18,027 Mil. Gross Profit was 1720.995 + 1695.48 + 1930.894 + 1710.105 = €7,057 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(31067.05 + 30778.5 + 30780.204 + 31517.724 + 32113.125) / 5 = €31251.3206 Mil. Total Assets at the begining of this year (Mar25) was €31,067 Mil. Long-Term Debt & Capital Lease Obligation was €9,029 Mil. Total Current Assets was €9,018 Mil. Total Current Liabilities was €7,378 Mil.
Net Income was 397.612 + 424.371 + 688.555 + 521.7 = €2,032 Mil.
Revenue was 4495.431 + 4381.563 + 5079.645 + 4418.725 = €18,375 Mil. Gross Profit was 1859.858 + 1824.525 + 2172.625 + 1861.1 = €7,718 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(29631.36 + 29590.508 + 30503.355 + 31599.995 + 31067.05) / 5 = €30478.4536 Mil. Total Assets at the begining of last year (Mar24) was €29,631 Mil. Long-Term Debt & Capital Lease Obligation was €6,533 Mil. Total Current Assets was €9,005 Mil. Total Current Liabilities was €9,221 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
GE HealthCare Technologies's current Net Income (TTM) was 1,641.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
GE HealthCare Technologies's current Cash Flow from Operations (TTM) was 1,734.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
GE HealthCare Technologies's return on assets of this year was 0.05281625. GE HealthCare Technologies's return on assets of last year was 0.06858403.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
GE HealthCare Technologies's gearing of this year was 0.28891163. GE HealthCare Technologies's gearing of last year was 0.21435717.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
GE HealthCare Technologies's current ratio of this year was 1.22241763. GE HealthCare Technologies's current ratio of last year was 0.97652723.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
GE HealthCare Technologies's number of shares in issue this year was 457. GE HealthCare Technologies's number of shares in issue last year was 459.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
GE HealthCare Technologies's gross margin of this year was 0.3914882. GE HealthCare Technologies's gross margin of last year was 0.42002477.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
GE HealthCare Technologies's asset turnover of this year was 0.58027064. GE HealthCare Technologies's asset turnover of last year was 0.62013232.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
0
+
1
+
1
+
0
+
0
=
5
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
GE HealthCare Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.
GE HealthCare Technologies (STU:L0T) has a Piotroski F-Score of 6 as of Jun. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on GE HealthCare Technologies and its competitors. This is near median its historical median of 6.00. Over the past decade, GE HealthCare Technologies' Piotroski F-Score has ranged from 5.00 to 8.00. According to the industry distribution chart, GE HealthCare Technologies ranks #153 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 19%.
Is GE HealthCare Technologies' Piotroski F-Score too high?
GE HealthCare Technologies' current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. GE HealthCare Technologies' value of 6 is 20% above this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #153 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Piotroski F-Score compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #153 out of 806 companies for Piotroski F-Score. This places GE HealthCare Technologies in the top 19% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. GE HealthCare Technologies' value of 6 is 20% above this benchmark. Historically, GE HealthCare Technologies' own Piotroski F-Score has ranged from 5.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, GE HealthCare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (STU:L0T) is currently considered Modestly Undervalued. The stock's GF Value™ is €74.58, compared to a current price of €56.83 — trading 23.8% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Medical Devices & Instruments industry median of 5.00. GE HealthCare Technologies' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For GE HealthCare Technologies (STU:L0T), the current Piotroski F-Score is 6 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (STU:L0T) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of €56.83 is trading 23.8% below its estimated GF Value™ of €74.58.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for STU:L0T:
Piotroski F-Score: 6 (near median its 10-year median of 6.00)
GF Value™: €74.58 vs. price of €56.83 (23.8% below fair value)
Industry Position: 20% above the Medical Devices & Instruments median (#153 of 806)
No single metric tells the full story. See the STU:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score
Get the complete analysis for STU:L0T
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:L0T has been successfully added to your 
